ZNF597

gene
On this page

Also known as FLJ33071HIT-4

Summary

ZNF597 (zinc finger protein 597, HGNC:26573) is a protein-coding gene on chromosome 16p13.3, encoding Zinc finger protein 597 (Q96LX8). May be involved in transcriptional regulation.

This gene encodes a protein with multiple zinc finger domains. Loss of the related gene in rodents results in defects in neural development and embryonic lethality in mutant homozygotes. This gene is adjacent to a differentially methylated region (DMR) and is imprinted and maternally expressed.

Source: NCBI Gene 146434 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 62 total
  • MANE Select transcript: NM_152457

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26573
Approved symbolZNF597
Namezinc finger protein 597
Location16p13.3
Locus typegene with protein product
StatusApproved
AliasesFLJ33071, HIT-4
Ensembl geneENSG00000167981
Ensembl biotypeprotein_coding
OMIM614685
Entrez146434

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000301744

RefSeq mRNA: 1 — MANE Select: NM_152457 NM_152457

CCDS: CCDS10505

Canonical transcript exons

ENST00000301744 — 4 exons

ExonStartEnd
ENSE0000111894634431213443206
ENSE0000111894734408073440933
ENSE0000111894834324143437538
ENSE0000111894934433603443504

Expression profiles

Bgee: expression breadth ubiquitous, 178 present calls, max score 95.91.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.9259 / max 75.2509, expressed in 1503 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1560313.81421498
1560320.111736

Top tissues by expression

253 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
secondary oocyteCL:000065595.91gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099186.69gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.88gold quality
oviduct epitheliumUBERON:000480476.30gold quality
oocyteCL:000002374.90gold quality
epithelial cell of pancreasCL:000008374.81silver quality
buccal mucosa cellCL:000233671.66gold quality
visceral pleuraUBERON:000240171.34gold quality
parietal pleuraUBERON:000240071.20gold quality
germinal epithelium of ovaryUBERON:000130470.70silver quality
granulocyteCL:000009470.38gold quality
stromal cell of endometriumCL:000225570.22gold quality
palpebral conjunctivaUBERON:000181269.95gold quality
islet of LangerhansUBERON:000000669.90gold quality
cortical plateUBERON:000534369.68gold quality
adrenal tissueUBERON:001830369.28gold quality
ventricular zoneUBERON:000305368.84gold quality
leukocyteCL:000073868.79gold quality
monocyteCL:000057668.42gold quality
calcaneal tendonUBERON:000370168.41gold quality
cartilage tissueUBERON:000241867.35silver quality
gall bladderUBERON:000211066.96gold quality
left adrenal glandUBERON:000123466.88gold quality
smooth muscle tissueUBERON:000113566.84gold quality
prefrontal cortexUBERON:000045166.73gold quality
descending thoracic aortaUBERON:000234566.59gold quality
left adrenal gland cortexUBERON:003582566.48gold quality
right adrenal gland cortexUBERON:003582766.48gold quality
embryoUBERON:000092266.43gold quality
ganglionic eminenceUBERON:000402366.43gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no3.94

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

153 targeting ZNF597, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4262100.0073.263931
HSA-MIR-4682100.0068.891258
HSA-MIR-3163100.0077.238605
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-1277-5P100.0073.955056
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-181A-5P99.9972.962995
HSA-MIR-181B-5P99.9972.972996
HSA-MIR-181C-5P99.9972.952996
HSA-MIR-181D-5P99.9973.042997
HSA-MIR-548AW99.9972.573559
HSA-MIR-548P99.9872.253784
HSA-MIR-1213699.9872.815713
HSA-MIR-25-3P99.9874.601817
HSA-MIR-32-5P99.9875.211964
HSA-MIR-363-3P99.9874.721821
HSA-MIR-367-3P99.9874.831819
HSA-MIR-92A-3P99.9875.211960
HSA-MIR-92B-3P99.9875.251955
HSA-MIR-60799.9773.625593
HSA-MIR-3688-3P99.9772.022834

Cross-species orthologs

7 orthologs

OrganismSymbolGene ID
danio_rerioprdm2aENSDARG00000090721
mus_musculusZfp597ENSMUSG00000039789
rattus_norvegicusZfp597ENSRNOG00000088895
drosophila_melanogasterCG12769FBGN0033252
caenorhabditis_elegansWBGENE00001223
caenorhabditis_elegansWBGENE00017406
caenorhabditis_elegansWBGENE00019960

Paralogs (7): ZNF423 (ENSG00000102935), ZNF211 (ENSG00000121417), ZNF462 (ENSG00000148143), ZBTB39 (ENSG00000166860), ZNF445 (ENSG00000185219), ZNF786 (ENSG00000197362), ZNF521 (ENSG00000198795)

Protein

Protein identifiers

Zinc finger protein 597Q96LX8 (reviewed: Q96LX8)

All UniProt accessions (1): Q96LX8

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Induction. Imprinted. Promoter methylation of the paternal allele may restrict expression to the maternal allele in leukocytes.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (1): NP_689670* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF01352

UniProt features (11 total): zinc finger region 7, chain 1, domain 1, sequence variant 1, cross-link 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96LX8-F148.970.00

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 300

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 92 (showing top): GGAANCGGAANY_UNKNOWN, PPAR_DR1_Q2, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, WARTERS_IR_RESPONSE_5GY, GOMF_DNA_BINDING_TRANSCRIPTION_ACTIVATOR_ACTIVITY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ASH1L_TARGET_GENES, CEBPZ_TARGET_GENES, MIR4262, MIR548P, MIR3121_3P, MIR106B_5P, MIR20A_5P, MIR181A_5P_MIR181B_5P

GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355), positive regulation of transcription by RNA polymerase II (GO:0045944)

GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228), zinc ion binding (GO:0008270), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transcription by RNA polymerase II2
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
regulation of DNA-templated transcription1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
regulation of transcription by RNA polymerase II1
positive regulation of DNA-templated transcription1
cis-regulatory region sequence-specific DNA binding1
DNA-binding transcription factor activity, RNA polymerase II-specific1
DNA-binding transcription activator activity1
positive regulation of transcription by RNA polymerase II1
transition metal ion binding1
double-stranded DNA binding1
sequence-specific DNA binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

606 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF597NAA60Q9H7X0723
ZNF597ADNPQ9H2P0608
ZNF597ZDBF2Q9HCK1587
ZNF597FAM50BQ9Y247507
ZNF597AASDHPPTQ9NRN7481
ZNF597MESTQ5EB52447
ZNF597USB1Q9BQ65433
ZNF597GNASQ5JWF2422
ZNF597MCTS2A0A3B3IRV3398
ZNF597HDGFP51858398
ZNF597NAP1L5Q96NT1381
ZNF597YBX1P16990377
ZNF597ZC3H12CQ9C0D7370
ZNF597CCDC185Q8N715360
ZNF597SNRPNP14648353

IntAct

44 interactions, top by confidence:

ABTypeScore
ZNF597TASOR2psi-mi:“MI:0914”(association)0.640
ZNF597SYT17psi-mi:“MI:0915”(physical association)0.560
ZNF597IRAK4psi-mi:“MI:0915”(physical association)0.560
ZNF597CIB3psi-mi:“MI:0915”(physical association)0.560
CASP6ZNF597psi-mi:“MI:0915”(physical association)0.560
DMWDZNF597psi-mi:“MI:0915”(physical association)0.560
LAMP2ZNF597psi-mi:“MI:0915”(physical association)0.560
LMNAZNF597psi-mi:“MI:0915”(physical association)0.560
RANZNF597psi-mi:“MI:0915”(physical association)0.560
OPTNZNF597psi-mi:“MI:0915”(physical association)0.560
PRPF40AZNF597psi-mi:“MI:0915”(physical association)0.560
ZNF597SPRED1psi-mi:“MI:0915”(physical association)0.560
ZNF597HCFC1psi-mi:“MI:0914”(association)0.530

BioGRID (44): ZNF597 (Two-hybrid), SMC6 (Affinity Capture-MS), NSMCE2 (Affinity Capture-MS), MPHOSPH8 (Affinity Capture-MS), NDNL2 (Affinity Capture-MS), SMC5 (Affinity Capture-MS), FAM208B (Affinity Capture-MS), NSMCE1 (Affinity Capture-MS), PPHLN1 (Affinity Capture-MS), NSMCE4A (Affinity Capture-MS), MPHOSPH8 (Affinity Capture-MS), SMC5 (Affinity Capture-MS), NSMCE2 (Affinity Capture-MS), FAM208B (Affinity Capture-MS), SMC6 (Affinity Capture-MS)

ESM2 similar proteins: A0JPL0, A1KXM5, A3CEM4, A6NK53, A7KBS4, A7MBI1, A8K554, A8MT65, A8MUZ8, A8MWA4, B1APH4, B2RXC5, E7ETH6, E9Q8G5, F4KIH4, G3X9G7, O14628, P0CH99, P0CI00, P18853, Q32L17, Q3MJ40, Q3URS2, Q49AA0, Q4V8E9, Q5EBM4, Q5FWF6, Q5RE50, Q5REN4, Q6V9R5, Q6ZN11, Q6ZN79, Q755V9, Q80VJ6, Q86TJ5, Q8BGV5, Q8N535, Q8N720, Q8N859, Q8NC26

Diamond homologs: O15391, P08045, P18712, P18731, P18732, P18747, P25490, P38621, Q00899, Q19A41, Q3TTC2, Q5EBL2, Q62255, Q86T29, Q86UQ0, Q8BI66, Q8BIQ3, Q8BX22, Q8CJ78, Q8ST83, Q8TBZ5, Q8TF50, Q96LX8, Q99PV8, Q9BXA9, Q9ER74, Q9H165, Q9H4T2, Q9NSC2, Q9QYE3, Q9UJQ4, Q9VHJ6, O15090, P98182, Q6NX45, Q8CF60, Q8K083, Q9NX65, Q9UL36, Q8N988

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

62 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance53
Likely benign4
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

531 predictions. Top by Δscore:

VariantEffectΔscore
16:3440802:CTTA:Cdonor_loss1.0000
16:3440804:TACC:Tdonor_loss1.0000
16:3440805:A:ACdonor_gain1.0000
16:3440805:AC:Adonor_gain1.0000
16:3440805:ACCCA:Adonor_loss1.0000
16:3440806:C:CCdonor_gain1.0000
16:3440806:CC:Cdonor_gain1.0000
16:3440806:CCCAT:Cdonor_gain1.0000
16:3440929:GGTCC:Gacceptor_gain1.0000
16:3440931:TCC:Tacceptor_gain1.0000
16:3440932:CC:Cacceptor_gain1.0000
16:3440932:CCC:Cacceptor_gain1.0000
16:3440933:CC:Cacceptor_gain1.0000
16:3440933:CCT:Cacceptor_loss1.0000
16:3440934:C:Aacceptor_loss1.0000
16:3440934:C:CCacceptor_gain1.0000
16:3440935:T:Gacceptor_loss1.0000
16:3443116:CTCA:Cdonor_loss1.0000
16:3443202:CAAAG:Cacceptor_gain1.0000
16:3443203:AAAG:Aacceptor_gain1.0000
16:3443204:AAG:Aacceptor_gain1.0000
16:3443205:AG:Aacceptor_gain1.0000
16:3443206:GCTG:Gacceptor_loss1.0000
16:3443207:C:CCacceptor_gain1.0000
16:3443208:T:Cacceptor_loss1.0000
16:3443354:ACTT:Adonor_loss1.0000
16:3443355:CTTA:Cdonor_loss1.0000
16:3443358:A:ACdonor_gain1.0000
16:3443359:C:CCdonor_gain1.0000
16:3443359:C:CGdonor_loss1.0000

AlphaMissense

2844 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
16:3437036:A:CF221L1.000
16:3437036:A:TF221L1.000
16:3437038:A:GF221L1.000
16:3436952:A:CF249L0.999
16:3436952:A:TF249L0.999
16:3436954:A:GF249L0.999
16:3437013:C:GR229P0.999
16:3437019:A:GL227P0.999
16:3437037:A:GF221S0.999
16:3437081:A:CH206Q0.999
16:3437081:A:TH206Q0.999
16:3437087:T:AR204S0.999
16:3437087:T:GR204S0.999
16:3437095:G:CH202D0.999
16:3437103:A:GL199P0.999
16:3437120:G:CF193L0.999
16:3437120:G:TF193L0.999
16:3437122:A:GF193L0.999
16:3437179:G:CH174D0.999
16:3437179:G:TH174N0.999
16:3437204:G:CF165L0.999
16:3437204:G:TF165L0.999
16:3437206:A:GF165L0.999
16:3436997:G:CH234Q0.998
16:3436997:G:TH234Q0.998
16:3437009:G:CH230Q0.998
16:3437009:G:TH230Q0.998
16:3437011:G:CH230D0.998
16:3437011:G:TH230N0.998
16:3437031:T:GQ223P0.998

dbSNP variants (sampled 300 via entrez): RS1000055627 (16:3443745 A>C), RS1000111807 (16:3444239 G>T), RS1000163608 (16:3440006 G>A,C), RS1000305342 (16:3440253 C>G), RS1000516334 (16:3441015 A>C), RS1000545509 (16:3441834 G>A,C), RS1000588466 (16:3441171 G>A,C), RS1000705420 (16:3438163 T>G), RS1001013482 (16:3437857 G>A), RS1001286985 (16:3444483 T>C), RS1001417976 (16:3440636 A>G), RS1001469987 (16:3440506 C>G,T), RS1001697270 (16:3444257 A>C), RS1001907957 (16:3431921 G>A), RS1001944160 (16:3435404 G>A)

Disease associations

OMIM: gene MIM:614685 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

27 total (human), top 27 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases methylation, increases expression2
Cisplatinaffects expression, increases expression2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
TAK-243increases sumoylation1
triphenyl phosphateaffects expression1
alpha-pineneaffects cotreatment, decreases expression, increases abundance1
2-methyl-4-isothiazolin-3-oneincreases expression1
terbufosincreases methylation1
methacrylaldehydeaffects cotreatment, decreases expression, increases abundance1
di-n-butylphosphoric acidaffects expression1
CGP 52608affects binding, increases reaction1
abrineincreases expression1
Temozolomideincreases expression1
Decitabineaffects expression1
Acroleinaffects cotreatment, decreases expression, increases abundance1
Air Pollutantsaffects cotreatment, decreases expression, increases abundance1
Doxorubicindecreases expression1
Fonofosincreases methylation1
Estradiolincreases expression1
Methyl Methanesulfonateincreases expression1
Ozoneaffects cotreatment, decreases expression, increases abundance1
Parathionincreases methylation1
Valproic Acidincreases methylation1
Aflatoxin B1increases methylation1
Cadmium Chloridedecreases expression1
Acrylamideincreases expression1
Volatile Organic Compoundsaffects cotreatment, decreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.